Funding Links #1

Scheme Details Typical timelines and budget
AZ Open Innovation Access AZ screening library against target of interest. Work carried out by AstraZeneca
BHF Translational Award Supports the pre-clinical development of new cardiovascular medicines and technologies so that they are attractive for follow-on funding: bridging the funding gap between promising innovations and the clinic £250k
CRUK Small Molecule Drug Discovery Project Awards Identify and characterise small molecule novel therapeutic targets and to identify and develop novel therapeutic entities for the benefit of cancer patients. New target identification & validation. One to three years, £300k
Eli Lilly Open Innovation Drug Discovery Scheme R & D Challenges: access screening libraries, in sillico design and synthesis. As required to progress project
European Lead Factory Access 300k (to 500k) ‘lead-like’ compounds to screen against a novel target. Generates qualified hit list of up to 50 compounds.
Must be in 384 format or demonstrate feasibility to be converted to 384.
Work carried out by European Lead Factory
GSK Discovery Fast Track Screening service against target of interest. Not always open. As required to progress project
GSK Discovery Partnership with Academia  Integrated GSK-academic partnerships that can translate innovative research  Six -12 months
Innovate UK Multiple schemes which are updated regularly, ranging from small innovation vouchers to large, collaborative programmes. Usually industry-led. Various
MRC Biomedical catalyst Early stage, small molecule, drug discovery.  Will fund development of therapeutics. Up to three years, £3M
Wellcome Trust Seed award Small, one-off grants to help researchers develop original and innovative ideas to a position where they would be able to be competitive for a larger award from the Wellcome Trust, or another source. Up to two years, £100k